KAREN J WILSON

CIK 1267490 · SVP, Finance & PAO · last filed 2026-05-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.26M

Companies

7

Total Filings

57

Lifetime Open-Market Net

-$11.48M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SER Director 10,000 $1.84 $18.4K $37.0K 3 2026-05-26
LAVA Therapeutics NV (LVTX) Delisted Director 0 $1.74 $0 $0 2 2025-11-17
ELTX Director $14.85 $0 3 2025-05-20
Elicio Therapeutics, Inc. (ANGN) Delisted Director 18,718 $10.00 $187.2K $0 3 2022-06-13
Vaxart, Inc. (VXRT) Delisted Director $0.32 $0 2 2021-06-17
JAZZ SVP, Finance & PAO 18,385 $230.56 $4.24M -$11.52M 43 2019-03-07
PDL BIOPHARMA, INC. (PDLI) Delisted VP of Finance & PAO 10,494 $0 1 2009-05-11

Recent Filings · Page 6 of 6

57 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-03-13 JAZZ Sell (S) −8,000 -$396.5K EDGAR
2012-01-18 JAZZ Grant (A) +10,292 $0 EDGAR
2012-01-18 JAZZ Disp (D) −10,292 $0 EDGAR
2012-01-13 JAZZ Mixed +10,086 -$291.9K EDGAR
2011-12-02 JAZZ Other (J) +206 $5.2K EDGAR
2011-03-11 JAZZ Grant (A) $0 EDGAR
2009-05-11 PDL BIOPHARMA, INC. (PDLI) Delisted Grant (A) +10,494 $0 EDGAR
Showing 5157 of 57
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.